BioSenic S.A. (EBR:BIOS)
0.0025
+0.0002 (8.70%)
Aug 15, 2025, 5:23 PM CET
BioSenic Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.82 | 0.12 | 1.85 | 0.76 |
Cash & Short-Term Investments | 0.82 | 0.12 | 1.85 | 0.76 |
Cash Growth | 57.23% | -93.66% | 143.22% | - |
Accounts Receivable | 0.27 | 0.45 | 1.21 | - |
Other Receivables | 1.06 | 0.98 | 1.2 | 0.36 |
Receivables | 1.34 | 1.44 | 2.41 | 0.36 |
Other Current Assets | 0.44 | 0.29 | 0.37 | 0 |
Total Current Assets | 2.59 | 1.85 | 4.63 | 1.12 |
Property, Plant & Equipment | 0.59 | 0.7 | 1.42 | 0.01 |
Long-Term Investments | 0.01 | 0.01 | 0.01 | - |
Goodwill | - | - | 1.8 | - |
Other Intangible Assets | 2.98 | 2.99 | 17.29 | - |
Long-Term Accounts Receivable | 0.32 | 0.4 | - | - |
Other Long-Term Assets | 2.9 | 3.62 | 4.17 | 0.03 |
Total Assets | 9.4 | 9.56 | 29.32 | 1.16 |
Accounts Payable | 2.6 | 3.59 | 1.99 | 0.21 |
Accrued Expenses | - | 0.05 | 0.04 | - |
Short-Term Debt | - | 5.64 | 2.98 | - |
Current Portion of Long-Term Debt | 3.08 | 5.82 | 4.8 | 1.25 |
Current Portion of Leases | 0.48 | 0.36 | 0.23 | - |
Current Income Taxes Payable | - | 0.01 | - | - |
Current Unearned Revenue | - | 0.05 | 0.06 | - |
Other Current Liabilities | 0.32 | 0.33 | 0.25 | 0.03 |
Total Current Liabilities | 6.49 | 15.84 | 10.35 | 1.49 |
Long-Term Debt | 22.61 | 15.57 | 14.78 | 2.27 |
Long-Term Leases | 0.63 | 0.77 | 1 | - |
Other Long-Term Liabilities | 0 | - | 0 | 0.07 |
Total Liabilities | 29.8 | 32.26 | 26.2 | 3.83 |
Common Stock | 8.18 | 6.28 | 4.77 | 0.66 |
Additional Paid-In Capital | 5.84 | 5.72 | 4.52 | 3.97 |
Retained Earnings | -34.4 | -34.89 | -5.72 | -7.22 |
Comprehensive Income & Other | -0.08 | -0.02 | -0.04 | -0.08 |
Total Common Equity | -20.47 | -22.91 | 3.53 | -2.67 |
Minority Interest | 0.06 | 0.21 | -0.4 | - |
Shareholders' Equity | -20.4 | -22.71 | 3.12 | -2.67 |
Total Liabilities & Equity | 9.4 | 9.56 | 29.32 | 1.16 |
Total Debt | 26.79 | 28.16 | 23.79 | 3.53 |
Net Cash (Debt) | -25.98 | -28.04 | -21.94 | -2.77 |
Net Cash Per Share | -0.15 | -0.20 | -0.18 | -41.86 |
Filing Date Shares Outstanding | 251.31 | 163.18 | 240.19 | 0.07 |
Total Common Shares Outstanding | 251.31 | 163.18 | 240.19 | 0.07 |
Working Capital | -3.9 | -14 | -5.73 | -0.37 |
Book Value Per Share | -0.08 | -0.14 | 0.01 | -40.40 |
Tangible Book Value | -23.45 | -25.9 | -15.57 | -2.67 |
Tangible Book Value Per Share | -0.09 | -0.16 | -0.06 | -40.40 |
Buildings | - | 0.92 | - | - |
Machinery | - | 0.08 | 0.07 | - |
Construction In Progress | - | - | 0.14 | - |
Updated Sep 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.